secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001437749-25-035245
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision Q3 revenue up 135% to $226K; net loss down 45% to $2.25M
---------------------------------------------------------------------------

- Total revenue Q3 2025: $226K, +135% YoY from $96K; nine-month revenue $581K, +114%.
- GAAP net loss Q3 2025: $2.25M, 45% reduction from $4.12M in Q3 2024.
- Nine-month net loss $11.4M vs $11.0M; non-cash charges $4.2M.
- CE Mark approval for LockeT driving international interest; reorders in South Africa and first French VIVO order.
- VIVO clinical studies completed in 2025; CEO expects major US and international expansion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000143774925035245/0001437749-25-035245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000143774925035245/vtak20251113_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-035245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer